SHAWN HERVEY-JUMPER
University of California San Francisco
Weill Institute for Neuroscience | Helen Diller Family Comprehensive Cancer Center
Professor Department of Neurological Surgery
Associate Program Director Neurosurgery Residency
Medical Director Neurosurgery
Director Glial Tumor Neuroplasticity Research Laboratory
Co-Director of the Sheri Sobrato Brisson Brain Cancer Survivorship Program
Principal Investigator, Brain Tumor Center | http://herveyjumperlab.ucsf.edu/
Weill Institute for Neuroscience | Helen Diller Family Comprehensive Cancer Center
Professor Department of Neurological Surgery
Associate Program Director Neurosurgery Residency
Medical Director Neurosurgery
Director Glial Tumor Neuroplasticity Research Laboratory
Co-Director of the Sheri Sobrato Brisson Brain Cancer Survivorship Program
Principal Investigator, Brain Tumor Center | http://herveyjumperlab.ucsf.edu/
Check the activity agenda
Monday, March 23, 2024
• Room 1
08:15-10:30
SESSION 3: DIFFUSE GLIOMAS
Cannabinoids in glioma treatment
How should be clinical and cognitive assessment in neurooncology?
Advances in patients specific brain mapping strategies
Is there any role for radiosurgery in recurrent gliomas?
The role of re-resection for recurrent IDHwt gliomas
Neuroplasticity and neuroprotection under the radiation oncologist view
Is dexamethasone still the best friend of neuro oncologist?
Discussion
Moderator: Joab Alves Nicacio Junior (SP)
Moderator: Lucas Alverne Freitas de Albuquerque (CE)
Moderator: Gustavo Matos (DF)
Cannabinoids in glioma treatment
Speaker: Juan Sepulveda (Espanha)
How should be clinical and cognitive assessment in neurooncology?
Speaker: Yvonne Kew (Estados Unidos)
Advances in patients specific brain mapping strategies
Speaker: Shawn Hervey-jumper (Estados Unidos)
Is there any role for radiosurgery in recurrent gliomas?
Speaker: Marcos Duarte de Mattos (SP)
The role of re-resection for recurrent IDHwt gliomas
Speaker: Sujit Prabhu (Estados Unidos)
Neuroplasticity and neuroprotection under the radiation oncologist view
Speaker: Fabio Ynoe de Moraes (Canadá)
Is dexamethasone still the best friend of neuro oncologist?
Speaker: Adrialdo José Santos (SP)
Discussion
12:15-13:15
NEW FRONTIRES IN LGG TREATMENT
LGG Clinical case
Navigating Low-Grade Glioma for Neurosurgeons: Key Decision Factors and Clinical Approaches
Translating recent clinical evidence in LGG into clinical practice
Q&A
LGG Clinical case
Speaker: Caroline Chaul (SP)
Navigating Low-Grade Glioma for Neurosurgeons: Key Decision Factors and Clinical Approaches
Speaker: Shawn Hervey-jumper (Estados Unidos)
Translating recent clinical evidence in LGG into clinical practice
Speaker: Juan Sepulveda (Espanha)
Q&A
Promoted by
Organization
Tourism agency
SILVER SPONSOR
BRONZE SPONSOR
SUPPORT SPONSOR
Institutional Support
